<DOC>
	<DOCNO>NCT02889055</DOCNO>
	<brief_summary>Current recommendation conduct sédationanalgésie ICU encourage use light possible sedation strategy , avoid administration benzodiazepine source long duration ventilation ICU stay syndrome cessation , mental confusion . Among proposed alternative , administration halogenated volatile agent ( sevoflurane ) resuscitation interest favorable pharmacokinetic even prolonged administration : tachyphylaxis , rapid clearance , withdrawal syndrome . There two suitable delivery device sevoflurane intensive care , CE mark . The device Mirus ™ ( Pall Medical , Fribourg , Switzerland ) new easy use reliable . The objective study evaluate use Mirus ™ device trauma resuscitation cardiovascular resuscitation . Specifically , use modality case failure conventional sedation product ( propofol , midazolam ) : maximum permissible dos , sedation weaning failure due severe agitation .</brief_summary>
	<brief_title>Evaluation Mirus™ Sedation Resuscitation</brief_title>
	<detailed_description />
	<criteria>Patients age 18 year In mechanical ventilation 48 hour No intracranial hypertension In severe state agitation measure sedation scale score great 2 RASS Agitation observe two circumstance : receive maximal dos propofol ( ≥ 5 mg / kg / h ) / midazolam ( ≥ 0.2 mg / kg / h ) , wean failure stop sedation agitation . Presence severe head injury ( Glasgow initial score 3 8 ) require monitor intracranial pressure / treatment intracranial hypertension Sedation dexmedetomidine Personal family antecedent anesthetic malignant hyperthermia Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>